Back to search results

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Abroad (travel likely)RecruitingPHASE2

Conditions

Sickle Cell Disease · Stem Cell Transplant Complications · Red Blood Cell Disorder · Pure Red Cell Aplasia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Alberta Children's Hospital, Calgary, Alberta, Canada

    Contact: Study coordinator (Tony Truong, MD, MPH) · tony.truong@ahs.ca · 403-955-7272
    Contact: Study coordinator (Greg Guilcher, MD) · 403-955-7272
    Contact: Principal Investigator (Tony Truong, MD, MPH)
    Greg Guilcher, MD (Sub-investigator)
    Victor Lewis, MD (Sub-investigator)
    Michael Leaker, MD (Sub-investigator)
    Aisha Bruce, MD (Sub-investigator)
    Aru Narendran, MD, PhD (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)